# Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Venlafaxine Hydrochloride Sustained-release Tablets in Patients With Major Depression Disorder

> **NCT06278038** · NA · COMPLETED · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 84 (actual)

## Conditions studied

- Major Depression Disorder

## Interventions

- **DRUG:** Toludesvenlafaxine hydrochloride sustained-release tablets
- **DRUG:** Venlafaxine hydrochloride sustained-release tablets

## Key facts

- **NCT ID:** NCT06278038
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-22
- **Primary completion:** 2024-11-10
- **Final completion:** 2024-11-19
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2025-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06278038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06278038, "Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Venlafaxine Hydrochloride Sustained-release Tablets in Patients With Major Depression Disorder". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT06278038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*